Nationwide Fund Advisors’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-72,085
Closed -$3.78M 435
2017
Q3
$3.78M Sell
72,085
-2,585
-3% -$130K 0.01% 1146
2017
Q2
$3.8M Buy
74,670
+11,999
+19% +$594K 0.02% 1145
2017
Q1
$2.78M Buy
62,671
+42,244
+207% +$1.82M 0.01% 1264
2016
Q4
$902K Sell
20,427
-53,063
-72% -$2.25M ﹤0.01% 1844
2016
Q3
$2.94M Sell
73,490
-1,600
-2% -$67.9K 0.01% 1220
2016
Q2
$3.58M Sell
75,090
-3,420
-4% -$145K 0.02% 1105
2016
Q1
$3.31M Sell
78,510
-5,348
-6% -$210K 0.01% 1127
2015
Q4
$3.69M Sell
83,858
-1,027
-1% -$44.6K 0.02% 1084
2015
Q3
$4.05M Buy
84,885
+937
+1% +$51.4K 0.02% 1021
2015
Q2
$4.89M Buy
83,948
+2,607
+3% +$141K 0.02% 978
2015
Q1
$4.11M Buy
81,341
+4,212
+5% +$206K 0.02% 1084
2014
Q4
$3.47M Buy
77,129
+2,754
+4% +$115K 0.01% 1136
2014
Q3
$2.74M Sell
74,375
-9,269
-11% -$368K 0.01% 1259
2014
Q2
$3.69M Buy
83,644
+7,937
+10% +$360K 0.02% 1154
2014
Q1
$3.29M Buy
75,707
+555
+0.7% +$24.7K 0.02% 1082
2013
Q4
$3.19M Buy
75,152
+27
+0% +$1.03K 0.01% 1200
2013
Q3
$2.55M Buy
75,125
+51,596
+219% +$1.68M 0.01% 1282
2013
Q2
$735K Buy
+23,529
New +$763K ﹤0.01% 1828

Other funds holding CNMD

Nationwide Fund Advisors's CNMD Position: Q4 2017 in Review

Nationwide Fund Advisors sold out of CONMED (CNMD) in Q4 2017, closing a stake of 72,085 shares — an estimated $3.78M sold.

Nationwide Fund Advisors first reported a position in CNMD in Q2 2013 and held it in 18 quarters. The position peaked at $4.89M in Q2 2015. 160 funds tracked by Wall St. Rank hold CNMD as of Q4 2017.

  • Nationwide Fund Advisors reported no remaining CONMED position as of Q4 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 72,085 CONMED shares in Q4 2017, an estimated $3.78M.
  • Nationwide Fund Advisors first reported a position in CONMED in Q2 2013 and held it in 18 quarters.
  • Nationwide Fund Advisors's CONMED position peaked at $4.89M in Q2 2015.
  • 160 funds tracked by Wall St. Rank held CONMED as of Q4 2017.

Based on Nationwide Fund Advisors's 13F filing for Q4 2017, filed 1 Feb 2018.